Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug by BY PAM BELLUCK AND REBECCA ROBBINS

This entry was posted in Health Weight Watchers and tagged Health NYT on by

The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.

Published: June 11, 2021 at 12:52AM

from NYT Health https://ift.tt/3veBqOD